< Back to previous page
Researcher
Katelijne De Nys
- Disciplines:Biomarker discovery and evaluation, Drug discovery and development, Medicinal products, Pharmaceutics, Pharmacognosy and phytochemistry, Pharmacology, Pharmacotherapy, Toxicology and toxinology, Other pharmaceutical sciences
Affiliations
- Clinical Pharmacology and Pharmacotherapy (Division)
Member
From1 Jul 2013 → 31 Aug 2020 - Department of Pharmaceutical and Pharmacological Sciences (Department)
Member
From1 Jan 2012 → 31 Aug 2022 - Faculty of Medicine (Faculty)
Member
From1 Oct 2009 → 31 Aug 2021 - Department of Cellular and Molecular Medicine (Department)
Member
From1 Oct 2008 → 31 Dec 2011
Publications
1 - 10 of 11
- It is time to revise the international Good Clinical Practices guidelines:recommendations from non-commercialNorth–South collaborative trials(2016)
Authors: Raffaella Ravinetto, Katelijne De Nys, Minne Casteels
- EMA maakt klinisch onderzoek transparanter(2015)
Authors: Gert Laekeman, Katelijne De Nys
Pages: 91 - 91 - Sponsorship in non-commercial clinical trials: definitions, challenges and the role of Good Clinical Practices guidelines(2015)
Authors: Raffaella Ravinetto, Katelijne De Nys, Minne Casteels
Pages: 34 - Predictors for reimbursement of oncology drugs in Belgium between 2002 and 2013(2015)
Authors: Kim Pauwels, Isabelle Huys, Katelijne De Nys, Minne Casteels, Steven Simoens
Pages: 859 - 868 - Predictors for reimbursement of oncology drugs in Belgium between 2002 and 2013(2015)
Authors: Kim Pauwels, Isabelle Huys, Katelijne De Nys, Minne Casteels, Steven Simoens
Pages: 859 - 868 - Market access of cancer drugs in European countries: improving resource allocation(2014)
Authors: Kim Pauwels, Isabelle Huys, Minne Casteels, Katelijne De Nys, Steven Simoens
Pages: 95 - 110 - Markttoegang van kankergeneesmiddelen: procedures voor prijszetting en terugbetaling in Europese landen(2014)
Authors: Kim Pauwels, Isabelle Huys, Minne Casteels, Katelijne De Nys, Steven Simoens
Pages: 1 - 6 - How often did Belgian physicians co-prescribe tamoxifen with strong CYP2D6 inhibitors over the last 6 years?(2014)
Authors: Anne-Sophie Dieudonné, Katelijne De Nys, Minne Casteels, Hans Wildiers, Patrick Neven
Pages: 47 - 52 - Market access of cancer drugs in European countries: a matter of setting priorities for resource allocation(2013)
Authors: Kim Pauwels, Isabelle Huys, Katelijne De Nys, Minne Casteels, Steven Simoens
Pages: A427 - A427 - A European approach to clinical investigator training(2013)
Authors: Katelijne De Nys